Deutsche Bank Aktiengesellschaft Initiates Coverage on Stevanato Group (NYSE:STVN)

Key Points

• Deutsche Bank initiated coverage of Stevanato Group with a “hold” rating. The company has a consensus “Moderate Buy” rating, based on two Strong Buy, two Buy and four Hold recommendations.
• Stevanato Group reported quarterly EPS of €0.14, slightly below the €0.15 consensus estimate, on revenue of €302 million. The stock opened at €19.81, with a market capitalization of approximately $6 billion.
• Institutional investors increased exposure, including new positions from Wellington Management and Ranger Investment Management, while insiders sold 21,926 shares worth about €459,738 over the past 90 days.

Equities research analysts at Deutsche Bank Aktiengesellschaft assumed coverage on shares of Stevanato Group (NYSE:STVN - Get Free Report) in a research report issued on Wednesday, Briefing.com reports. The brokerage set a "hold" rating on the stock.

Several other research analysts have also commented on STVN. UBS Group assumed coverage on shares of Stevanato Group in a research note on Wednesday, September 9th. They issued a "neutral" rating and a $23.00 price objective for the company. TD Cowen upgraded shares of Stevanato Group to a "strong-buy" rating in a report on Wednesday, June 17th. Finally, Weiss Ratings raised shares of Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, August 27th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy".

Stevanato Group Price Performance

STVN stock opened at €19.81 on Wednesday. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $6.00 billion, a PE ratio of 35.37, a P/E/G ratio of 1.64 and a beta of 0.78. Stevanato Group has a 12-month low of €12.89 and a 12-month high of €27.99. The business's fifty day moving average price is €21.10 and its 200 day moving average price is €18.55.

Stevanato Group (NYSE:STVN - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.15 by (€0.01). The firm had revenue of €302.00 million for the quarter. Stevanato Group had a return on equity of 10.43% and a net margin of 10.99%. On average, sell-side analysts anticipate that Stevanato Group will post 0.69 EPS for the current year.

Insider Buying and Selling

In other news, insider Mauro Stocchi sold 13,649 shares of the business's stock in a transaction dated Monday, September 28th. The stock was sold at an average price of €21.50, for a total transaction of €293,453.50. Following the completion of the transaction, the insider directly owned 400,000 shares of the company's stock, valued at approximately €8,600,000. The trade was a 3.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Marco Dal Lago sold 4,209 shares of the company's stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of €20.09, for a total transaction of €84,558.81. Following the sale, the chief financial officer owned 81,144 shares in the company, valued at €1,630,182.96. The trade was a 4.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 21,926 shares of company stock valued at $459,738.

Institutional Investors Weigh In On Stevanato Group

Several institutional investors have recently modified their holdings of STVN. Wellington Management Group LLP purchased a new position in Stevanato Group in the second quarter valued at approximately $22,621,000. Ranger Investment Management L.P. acquired a new position in shares of Stevanato Group in the 2nd quarter valued at $21,438,000. Conestoga Capital Advisors LLC grew its position in shares of Stevanato Group by 7.6% in the 1st quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company's stock valued at $116,762,000 after buying an additional 602,050 shares during the last quarter. Confluence Investment Management LLC purchased a new position in shares of Stevanato Group in the 2nd quarter valued at $6,062,000. Finally, Roubaix Capital LLC raised its stake in Stevanato Group by 96.6% during the 1st quarter. Roubaix Capital LLC now owns 385,316 shares of the company's stock worth $5,298,000 after acquiring an additional 189,343 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.